Search
for
Sort by
Research 31–60 of 530
- Alopecia areata: Ritlecitinib generates substantial re-growth of scalp hair
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- 046 Analysing the mechanistic basis of Ritlecitinib’s therapeutic effects in Alopecia Areata
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- Cost‐Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 years of Age With Severe Alopecia Areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Pharmacotherapy of alopecia areata
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Kaempferol enhances hair growth by regulating JAK3/STAT6 and TGF-β/Smad signaling in human dermal papilla cells and a C57BL/6 mousemodel
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Treatment of alopecia areata with JAK inhibitors: a review of the literature